https://3w.huanqiu.com/a/de583b/3zsBPe8hEpj?agt=8
四天单日“9万+”确诊！印度新冠病例不断刷新纪录，莫迪喊话不可大意
2020-09-14 02:46 胡博峰
【环球时报驻印度特派记者 胡博峰】据印度卫生部消息，截至当地时间9月13日早8时，印度新冠肺炎累计确诊病例已升至4754357例，其中累计死亡78586例，累计治愈3702596例。在过去24小时内，印度共新增94372例，这已是印度连续四天录得单日“9万+”确诊病例。今年9月以来，印度在短短12天内累计确诊病例就突破了100万。对比上月，印度8月份累计报告了约198万确诊病例，专家表示，如果这一趋势延续下去，9月份的累计确诊病例将比上个月更多。
目前，印度疫情暴发点较为集中，但也面临一些防控初见成效地区疫情恶化的挑战。《印度斯坦时报》13日报道称，马哈拉施特拉邦、安德拉邦、泰米尔纳德邦、卡纳塔克邦、北方邦目前仍是确诊病例最多的地方邦，占全印累计确诊病例总数的近57%。其中，仅马哈拉施特拉邦的累计确诊病例就已突破100万。
即便如此，印度卫生部坚持认为，印度约77.88%的治愈率和约1.65%的死亡率均位列全球前列。此前疫情一度得到控制的印度首都新德里及其周边地区12日单日确诊病例达到4321例，刷新了此前纪录，累计确诊病例升至21.4万。
令人担心的是，新德里7日刚刚恢复部分地铁线路运营，并计划继续放松对餐馆、酒店等的管控措施。据《印度时报》13日报道，此前患新冠肺炎已治愈出院的印度内政部长阿米特·沙阿12日晚再次被送往全印医学院，但目前还不知道是否与再度感染有关。不过，全印医学院13日发布的新闻稿表示，前期出院时的医嘱要求沙阿在下周议会会议召开前进行例行身体检查。
面对疫情严峻形势，印度总理莫迪12日再次公开喊话，要求民众做好各项防护措施，“切记不可大意”。《印度时报》的报道说，莫迪是在当天出席中央邦的一场视频活动期间作出上述表态的。他强调，“在新冠肺炎疫苗和特效药问世之前”，保持安全的社交距离、佩戴口罩等措施非常有必要。报道说，印度目前有7家本土制药公司参与新冠疫苗研发和后续生产，其中“印度制造”的Covaxin疫苗已完成实验室和动物安全性测试，第一阶段临床试验也表现出“显著的免疫效果”。
在此背景下，饱受各方争议的“全印医学入学资格考试”13日在各地正式“开锣”。此前，印度最高法院否决了推迟举行“全印医学入学资格考试”和“工科资格联合入学考试”的动议，而后者已于9月1日至6日完成全部考试科目。由于部分地方邦为防控疫情，近段时间以来又恢复了封锁措施，有可能导致参加考试的学生无法抵达考场。为此，西孟加拉邦、旁遮普邦、奥里萨邦均发布了旨在为考生出行、住宿等提供方便的临时政策，如短暂取消宵禁、开通特殊地铁专列等。新德里电视台13日报道说，政府已经发布了一项完整的应试期间疫情防控指南，包括考试需戴口罩、手套，携带消毒水等，以防止发生聚集性感染。
对于大多数印度普通民众来说，除了加强个人防护措施之外，更为关心的是“如果感染了，治疗费怎么办”。尽管印度内政部此前发布政令，对公、私立医院的新冠肺炎治疗费用进行了限制，但对大多数印度人来说仍然不菲。例如，隔离病床的费用是每天8000至1万卢比（1卢比约合0.1元人民币），配有呼吸机设备的重症监护室费用是每天1.5万至1.8万卢比。而这还不包括个人防护品等其他衍生费用。正因为此，印度医疗保险业在疫情期间表现非常抢眼。
据印度媒体统计，自疫情暴发以来，印度网上商业医疗保险销量猛增30%至40%，投保金额也从疫情前的平均50万卢比大幅提升至250万至1千万卢比。为此，印度保险业监管与发展局要求印度所有医疗保险公司专门制定两款基于新冠肺炎治疗的新保险方案，并于今年7月推向市场。一旦投保人确诊，这两款保险方案都将在其入院72小时内提供与投保金额等额的一次性治疗补贴，医护人员购买保险还可享受5%的优惠。不过，该方案对投保人的年龄设置了65岁的上限。《印度时报》此前的一篇报道援引某知名保险公司的话说，两款新冠保险方案尤其受欢迎，每天可出售大约200至300份保单。
责编：赵建东
"90,000+" diagnosed in four days and one day! India's new crown cases keep breaking records, Modi shouts not to be careless
2020-09-14 02:46 Hu Bofeng
[Global Times Special Correspondent in India Hu Bofeng] According to the Indian Ministry of Health, as of 8 a.m. local time on September 13, the cumulative number of confirmed cases of new coronary pneumonia in India has risen to 4,754,357, including 78,586 deaths and 3,702,596 cured cases. In the past 24 hours, India has added 94,372 new cases. This is the fourth consecutive day that India has recorded "90,000+" confirmed cases in a single day. Since September this year, the cumulative number of confirmed cases in India has exceeded 1 million in just 12 days. Compared with the previous month, India reported a total of about 1.98 million confirmed cases in August. Experts said that if this trend continues, the cumulative number of confirmed cases in September will be more than that of the previous month.
At present, the outbreak of the epidemic in India is relatively concentrated, but it also faces the challenge of worsening the epidemic in some areas where prevention and control have achieved initial results. The Hindustan Times reported on the 13th that Maharashtra, Andhra Pradesh, Tamil Nadu, Karnataka, and Uttar Pradesh are still the local states with the most confirmed cases, accounting for all of India Almost 57% of the total number of confirmed cases. Among them, the cumulative number of confirmed cases in Maharashtra alone has exceeded 1 million.
Even so, the Ministry of Health of India insists that India has a cure rate of about 77.88% and a mortality rate of about 1.65%. The number of confirmed cases in the Indian capital New Delhi and its surrounding areas reached 4321 on the 12th, breaking the previous record, and the cumulative number of confirmed cases rose to 214,000.
What is worrying is that New Delhi just resumed part of the subway line operation on the 7th, and plans to continue to loosen control measures on restaurants, hotels, etc. According to the “Times of India” report on the 13th, Indian Interior Minister Amit Shah, who had been cured and discharged from the hospital after suffering from new coronary pneumonia, was sent to the All India Medical College again on the evening of the 12th, but it is not known whether it is related to the re-infection. However, a press release issued by the All India Medical College on the 13th stated that the doctor’s order at the time of discharge required Shah to undergo a routine physical examination before the parliament meeting next week.
Faced with the severe situation of the epidemic, Indian Prime Minister Modi once again publicly shouted on the 12th, asking the public to take various protective measures, "remember not to be careless." The Times of India reported that Modi made the above statement during a video event in Madhya Pradesh that day. He emphasized that "before the new crown pneumonia vaccine and specific medicines are available", it is very necessary to maintain safe social distance and wear masks. According to the report, there are currently seven local pharmaceutical companies in India participating in the development and subsequent production of the new crown vaccine. Among them, the "Made in India" Covaxin vaccine has completed laboratory and animal safety tests, and the first phase of clinical trials also showed "significant immune effects." ".
In this context, the "All India Medical Entrance Examination", which has been controversial by all parties, was officially "launched" in various places on the 13th. Earlier, the Supreme Court of India rejected a motion to postpone the "All India Medical Entrance Examination" and the "Joint Entrance Examination for Engineering Qualifications", which had completed all examination subjects from September 1 to 6. As some local states have resumed blockade measures in order to prevent and control the epidemic, it may prevent students taking the exam from reaching the exam room. To this end, West Bengal, Punjab, and Odisha have all issued temporary policies aimed at facilitating the travel and accommodation of candidates, such as temporarily lifting the curfew and opening special subway trains. New Delhi TV reported on the 13th that the government has issued a complete guideline for the prevention and control of the epidemic during the test period, including masks, gloves, and disinfectant for the test to prevent cluster infections.
For most ordinary Indians, in addition to strengthening personal protection measures, they are more concerned about "if they are infected, what will happen to the treatment fee". Although India’s Ministry of the Interior has previously issued a decree restricting the cost of new coronary pneumonia treatment in public and private hospitals, it is still expensive for most Indians. For example, the cost of an isolation bed is 8,000 to 10,000 rupees per day (1 rupe is about 0.1 yuan), and the cost of an intensive care unit equipped with ventilator equipment is 15,000 to 18,000 rupees per day. And this does not include other derivative costs such as personal protective equipment. Because of this, the Indian medical insurance industry performed very well during the epidemic.
According to Indian media statistics, since the outbreak of the epidemic, online commercial medical insurance sales in India have soared by 30% to 40%, and the insured amount has also risen from an average of 500,000 rupees before the epidemic to 2.5 million to 10 crore rupees. To this end, the Insurance Regulatory and Development Authority of India requires all medical insurance companies in India to formulate two new insurance plans based on the treatment of new coronary pneumonia and launch them on the market in July this year. Once the insured is diagnosed, both insurance plans will provide a one-time treatment subsidy equal to the insured amount within 72 hours of admission. Medical staff can also enjoy a 5% discount when purchasing insurance. However, the plan sets an upper limit of 65 years for the age of policyholders. A previous report in The Times of India quoted a well-known insurance company as saying that the two new crown insurance schemes are particularly popular, with approximately 200 to 300 insurance policies sold every day.
Editor in charge: Zhao Jiandong
四天单日“9万+”确诊！印度新冠病例不断刷新纪录，莫迪喊话不可大意
2020-09-14 02:46 胡博峰
【环球时报驻印度特派记者 胡博峰】据印度卫生部消息，截至当地时间9月13日早8时，印度新冠肺炎累计确诊病例已升至4754357例，其中累计死亡78586例，累计治愈3702596例。在过去24小时内，印度共新增94372例，这已是印度连续四天录得单日“9万+”确诊病例。今年9月以来，印度在短短12天内累计确诊病例就突破了100万。对比上月，印度8月份累计报告了约198万确诊病例，专家表示，如果这一趋势延续下去，9月份的累计确诊病例将比上个月更多。
目前，印度疫情暴发点较为集中，但也面临一些防控初见成效地区疫情恶化的挑战。《印度斯坦时报》13日报道称，马哈拉施特拉邦、安德拉邦、泰米尔纳德邦、卡纳塔克邦、北方邦目前仍是确诊病例最多的地方邦，占全印累计确诊病例总数的近57%。其中，仅马哈拉施特拉邦的累计确诊病例就已突破100万。
即便如此，印度卫生部坚持认为，印度约77.88%的治愈率和约1.65%的死亡率均位列全球前列。此前疫情一度得到控制的印度首都新德里及其周边地区12日单日确诊病例达到4321例，刷新了此前纪录，累计确诊病例升至21.4万。
令人担心的是，新德里7日刚刚恢复部分地铁线路运营，并计划继续放松对餐馆、酒店等的管控措施。据《印度时报》13日报道，此前患新冠肺炎已治愈出院的印度内政部长阿米特·沙阿12日晚再次被送往全印医学院，但目前还不知道是否与再度感染有关。不过，全印医学院13日发布的新闻稿表示，前期出院时的医嘱要求沙阿在下周议会会议召开前进行例行身体检查。
面对疫情严峻形势，印度总理莫迪12日再次公开喊话，要求民众做好各项防护措施，“切记不可大意”。《印度时报》的报道说，莫迪是在当天出席中央邦的一场视频活动期间作出上述表态的。他强调，“在新冠肺炎疫苗和特效药问世之前”，保持安全的社交距离、佩戴口罩等措施非常有必要。报道说，印度目前有7家本土制药公司参与新冠疫苗研发和后续生产，其中“印度制造”的Covaxin疫苗已完成实验室和动物安全性测试，第一阶段临床试验也表现出“显著的免疫效果”。
在此背景下，饱受各方争议的“全印医学入学资格考试”13日在各地正式“开锣”。此前，印度最高法院否决了推迟举行“全印医学入学资格考试”和“工科资格联合入学考试”的动议，而后者已于9月1日至6日完成全部考试科目。由于部分地方邦为防控疫情，近段时间以来又恢复了封锁措施，有可能导致参加考试的学生无法抵达考场。为此，西孟加拉邦、旁遮普邦、奥里萨邦均发布了旨在为考生出行、住宿等提供方便的临时政策，如短暂取消宵禁、开通特殊地铁专列等。新德里电视台13日报道说，政府已经发布了一项完整的应试期间疫情防控指南，包括考试需戴口罩、手套，携带消毒水等，以防止发生聚集性感染。
对于大多数印度普通民众来说，除了加强个人防护措施之外，更为关心的是“如果感染了，治疗费怎么办”。尽管印度内政部此前发布政令，对公、私立医院的新冠肺炎治疗费用进行了限制，但对大多数印度人来说仍然不菲。例如，隔离病床的费用是每天8000至1万卢比（1卢比约合0.1元人民币），配有呼吸机设备的重症监护室费用是每天1.5万至1.8万卢比。而这还不包括个人防护品等其他衍生费用。正因为此，印度医疗保险业在疫情期间表现非常抢眼。
据印度媒体统计，自疫情暴发以来，印度网上商业医疗保险销量猛增30%至40%，投保金额也从疫情前的平均50万卢比大幅提升至250万至1千万卢比。为此，印度保险业监管与发展局要求印度所有医疗保险公司专门制定两款基于新冠肺炎治疗的新保险方案，并于今年7月推向市场。一旦投保人确诊，这两款保险方案都将在其入院72小时内提供与投保金额等额的一次性治疗补贴，医护人员购买保险还可享受5%的优惠。不过，该方案对投保人的年龄设置了65岁的上限。《印度时报》此前的一篇报道援引某知名保险公司的话说，两款新冠保险方案尤其受欢迎，每天可出售大约200至300份保单。
责编：赵建东
"90,000+" diagnosed in four days and one day! India's new crown cases keep breaking records, Modi shouts not to be careless
2020-09-14 02:46 Hu Bofeng
[Global Times Special Correspondent in India Hu Bofeng] According to the Indian Ministry of Health, as of 8 a.m. local time on September 13, the cumulative number of confirmed cases of new coronary pneumonia in India has risen to 4,754,357, including 78,586 deaths and 3,702,596 cured cases. In the past 24 hours, India has added 94,372 new cases. This is the fourth consecutive day that India has recorded "90,000+" confirmed cases in a single day. Since September this year, the cumulative number of confirmed cases in India has exceeded 1 million in just 12 days. Compared with the previous month, India reported a total of about 1.98 million confirmed cases in August. Experts said that if this trend continues, the cumulative number of confirmed cases in September will be more than that of the previous month.
At present, the outbreak of the epidemic in India is relatively concentrated, but it also faces the challenge of worsening the epidemic in some areas where prevention and control have achieved initial results. The Hindustan Times reported on the 13th that Maharashtra, Andhra Pradesh, Tamil Nadu, Karnataka, and Uttar Pradesh are still the local states with the most confirmed cases, accounting for all of India Almost 57% of the total number of confirmed cases. Among them, the cumulative number of confirmed cases in Maharashtra alone has exceeded 1 million.
Even so, the Ministry of Health of India insists that India has a cure rate of about 77.88% and a mortality rate of about 1.65%. The number of confirmed cases in the Indian capital New Delhi and its surrounding areas reached 4321 on the 12th, breaking the previous record, and the cumulative number of confirmed cases rose to 214,000.
What is worrying is that New Delhi just resumed part of the subway line operation on the 7th, and plans to continue to loosen control measures on restaurants, hotels, etc. According to the “Times of India” report on the 13th, Indian Interior Minister Amit Shah, who had been cured and discharged from the hospital after suffering from new coronary pneumonia, was sent to the All India Medical College again on the evening of the 12th, but it is not known whether it is related to the re-infection. However, a press release issued by the All India Medical College on the 13th stated that the doctor’s order at the time of discharge required Shah to undergo a routine physical examination before the parliament meeting next week.
Faced with the severe situation of the epidemic, Indian Prime Minister Modi once again publicly shouted on the 12th, asking the public to take various protective measures, "remember not to be careless." The Times of India reported that Modi made the above statement during a video event in Madhya Pradesh that day. He emphasized that "before the new crown pneumonia vaccine and specific medicines are available", it is very necessary to maintain safe social distance and wear masks. According to the report, there are currently seven local pharmaceutical companies in India participating in the development and subsequent production of the new crown vaccine. Among them, the "Made in India" Covaxin vaccine has completed laboratory and animal safety tests, and the first phase of clinical trials also showed "significant immune effects." ".
In this context, the "All India Medical Entrance Examination", which has been controversial by all parties, was officially "launched" in various places on the 13th. Earlier, the Supreme Court of India rejected a motion to postpone the "All India Medical Entrance Examination" and the "Joint Entrance Examination for Engineering Qualifications", which had completed all examination subjects from September 1 to 6. As some local states have resumed blockade measures in order to prevent and control the epidemic, it may prevent students taking the exam from reaching the exam room. To this end, West Bengal, Punjab, and Odisha have all issued temporary policies aimed at facilitating the travel and accommodation of candidates, such as temporarily lifting the curfew and opening special subway trains. New Delhi TV reported on the 13th that the government has issued a complete guideline for the prevention and control of the epidemic during the test period, including masks, gloves, and disinfectant for the test to prevent cluster infections.
For most ordinary Indians, in addition to strengthening personal protection measures, they are more concerned about "if they are infected, what will happen to the treatment fee". Although India’s Ministry of the Interior has previously issued a decree restricting the cost of new coronary pneumonia treatment in public and private hospitals, it is still expensive for most Indians. For example, the cost of an isolation bed is 8,000 to 10,000 rupees per day (1 rupe is about 0.1 yuan), and the cost of an intensive care unit equipped with ventilator equipment is 15,000 to 18,000 rupees per day. And this does not include other derivative costs such as personal protective equipment. Because of this, the Indian medical insurance industry performed very well during the epidemic.
According to Indian media statistics, since the outbreak of the epidemic, online commercial medical insurance sales in India have soared by 30% to 40%, and the insured amount has also risen from an average of 500,000 rupees before the epidemic to 2.5 million to 10 crore rupees. To this end, the Insurance Regulatory and Development Authority of India requires all medical insurance companies in India to formulate two new insurance plans based on the treatment of new coronary pneumonia and launch them on the market in July this year. Once the insured is diagnosed, both insurance plans will provide a one-time treatment subsidy equal to the insured amount within 72 hours of admission. Medical staff can also enjoy a 5% discount when purchasing insurance. However, the plan sets an upper limit of 65 years for the age of policyholders. A previous report in The Times of India quoted a well-known insurance company as saying that the two new crown insurance schemes are particularly popular, with approximately 200 to 300 insurance policies sold every day.
Editor in charge: Zhao Jiandong
